Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Epidemiology of metabolic dysfunction-associated steatotic liver disease

Zobair M. Younossi, Markos Kalligeros, Linda Henry

Clin Mol Hepatol. 2025;31(Suppl):S32-S50. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0431

View: 7238 Download: 1,605 Crossref: 19

Original Article

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation

Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi

Clin Mol Hepatol. 2025;31(1):131-146. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0451

View: 1399 Download: 174

Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis

Ji Won Han, Hee Yeon Kim, Jung Hwan Yu, Mi Na Kim, Young Eun Chon, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Han Ah Lee, Dae Won Jun

Clin Mol Hepatol. 2024;30(Suppl):S147-S158. Published online July 25, 2024

DOI: https://doi.org/10.3350/cmh.2024.0330

View: 2084 Download: 130 Web of Science: 4 Crossref: 4

Review

Screening strategy for non-alcoholic fatty liver disease

Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto

Clin Mol Hepatol. 2023;29(Suppl):S103-S122. Published online November 30, 2022

DOI: https://doi.org/10.3350/cmh.2022.0336

View: 6430 Download: 269 Web of Science: 19 Crossref: 19

Risk factors in nonalcoholic fatty liver disease

Eunji Ko, Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(Suppl):S79-S85. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0398

View: 6288 Download: 267 Web of Science: 36 Crossref: 41

Original Article

Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection

Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon

Clin Mol Hepatol. 2023;29(4):1029-1042. Published online August 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0190

View: 4173 Download: 166 Web of Science: 6 Crossref: 5

Editorial

Implications of comorbidities in nonalcoholic fatty liver disease

Sherlot Juan Song, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2023;29(2):384-389. Published online March 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0066

View: 4567 Download: 95 Web of Science: 2 Crossref: 2

Review

Development and prognosis of hepatocellular carcinoma in patients with diabetes

Takuma Nakatsuka, Ryosuke Tateishi

Clin Mol Hepatol. 2023;29(1):51-64. Published online July 29, 2022

DOI: https://doi.org/10.3350/cmh.2022.0095

View: 6811 Download: 265 Web of Science: 32 Crossref: 34

Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases

Hwang Sik Shin, Baek Gyu Jun, Sang-Wook Yi

Clin Mol Hepatol. 2022;28(4):773-789. Published online August 8, 2022

DOI: https://doi.org/10.3350/cmh.2021.0383

View: 6532 Download: 262 Web of Science: 38 Crossref: 41

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review

Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng

Clin Mol Hepatol. 2022;28(4):725-738. Published online March 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0015

View: 6088 Download: 266 Web of Science: 14 Crossref: 17

Original Article

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease

Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah

Clin Mol Hepatol. 2022;28(3):565-574. Published online May 19, 2022

DOI: https://doi.org/10.3350/cmh.2022.0096

View: 9346 Download: 221 Web of Science: 55 Crossref: 60

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods

Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park

Clin Mol Hepatol. 2022;28(1):105-116. Published online October 15, 2021

DOI: https://doi.org/10.3350/cmh.2021.0174

View: 8530 Download: 232 Web of Science: 9 Crossref: 11

Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes

Hydar El Jamaly, Guy D Eslick, Martin Weltman

Clin Mol Hepatol. 2022;28(1):52-66. Published online September 17, 2021

DOI: https://doi.org/10.3350/cmh.2021.0205

View: 8510 Download: 242 Web of Science: 15 Crossref: 19

Editorial

Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment

Ja-Young Kwon

Clin Mol Hepatol. 2022;28(1):50-51. Published online November 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0359

View: 4830 Download: 108

Review

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?

Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee, On behalf of Korean NAFLD Study Group

Clin Mol Hepatol. 2021;27(2):257-269. Published online March 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0067

View: 10142 Download: 446 Web of Science: 69 Crossref: 71

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease

Kyung-Soo Kim, Byung-Wan Lee

Clin Mol Hepatol. 2020;26(4):430-443. Published online August 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0137

View: 11406 Download: 500 Web of Science: 46 Crossref: 48

Original Article

Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes

Ebrahim Banitalebi, Mohammad Faramarzi, Samira Nasiri, Majid Mardaniyan, Vahid Rabiee

Clin Mol Hepatol. 2019;25(3):294-304. Published online May 30, 2019

DOI: https://doi.org/10.3350/cmh.2018.0086

View: 8330 Download: 273 Web of Science: 15 Crossref: 19

Case Report

Three cases of glycogenic hepatopathy mimicking acute and relapsing hepatitis in type I diabetes mellitus

Jae Hwang Cha, Sang Ho Ra, Yu Mi Park, Yong Kwan Ji, Ji Hyun Lee, So Yeon Park, Soon Koo Baik, Sang Ok Kwon, Mee Yon Cho, Moon Young Kim

Clin Mol Hepatol. 2013;19(4):421-425. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.421

View: 8900 Download: 82 Crossref: 24

4

Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C

Yun Nah Lee, M.D., Soung Won Jeong, M.D., Jae Hee Lim, M.D., Yang Seon Ryu, M.D., Seong Ran Jeon, M.D., Sang Kyun Kim, M.D., Jae Young Jang, M.D., Young Seok Kim, M.D., Boo Sung Kim, M.D., Mi Oh Roh, M.D.

Clin Mol Hepatol. 2010;16(2):187-191. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.187

View: 6393 Download: 32 Crossref: 1

3

Clinical features of gas-forming Liver abscesses: comparison between diabetic and nondiabetic patients

Chang Jae Lee, M.D., Sang Young Han, M.D., Sung Wook Lee, M.D., Yang Hyun Baek, M.D., Seok Reyol Choi, M.D., Myung Hwan Roh, M.D., Jong Hoon Lee, M.D., Jin Seok Jang, M.D., Jin Han, M.D., Su Hyun Cho, M.D., Se Woong Choi, M.D.

Clin Mol Hepatol. 2010;16(2):131-138. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.131

View: 5572 Download: 76 Crossref: 11

Differential Diagnosis of Diabetes Mellitus caused by Liver Cirrhosis and Other Type 2 Diabetes Mellitus

Min Geun Kim , Won Choong Choi

Clin Mol Hepatol. 2006;12(4):524-529. Published online January 1, 1970

View: 4546 Download: 129

Prevalence and Clinical Significance of Diabetes Mellitus in Patients with Liver Cirrhosis

Kwon So Yeong

Clin Mol Hepatol. 2003;9(3):205-211. Published online January 1, 1970

View: 3140 Download: 29

2

Special Liver Cirrhosis and Diabetes Mellitus

Yong Soo Park,Tae Wha Kim

Clin Mol Hepatol. 2002;8(1):22-34. Published online January 1, 1970

View: 2655 Download: 18

Original Article

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C

Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang

Received October 12, 2024 Accepted January 5, 2025

DOI: https://doi.org/10.3350/cmh.2024.0904 [Accepted]

View: 477 Download: 54 Crossref: 1

1 |

Viewed By 6971	MAFLD: How is it different from NAFLD?
Viewed By 6219	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5315	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5147	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4664	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 266	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 170	MAFLD: How is it different from NAFLD?
Cited By 92	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search